Manulife (Manufacturers Life Insurance)
NVAX icon

Manulife (Manufacturers Life Insurance)’s Novavax NVAX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$614K Sell
65,202
-1,308
-2% -$11.7K ﹤0.01% 2153
2026
Q1 		$541K Sell
66,510
-3,311
-5% -$30K ﹤0.01% 2127
2025
Q4 		$469K Sell
69,821
-4,726
-6% -$35.6K ﹤0.01% 2204
2025
Q3 		$646K Sell
74,547
-3,501
-4% -$27.2K ﹤0.01% 2083
2025
Q2 		$492K Buy
78,048
+1,718
+2% +$11.4K ﹤0.01% 2185
2025
Q1 		$489K Buy
76,330
+2,822
+4% +$23.3K ﹤0.01% 2154
2024
Q4 		$591K Sell
73,508
-6,275
-8% -$60.5K ﹤0.01% 2157
2024
Q3 		$1.01M Buy
79,783
+20,127
+34% +$260K ﹤0.01% 1925
2024
Q2 		$755K Buy
59,656
+20,709
+53% +$208K ﹤0.01% 2005
2024
Q1 		$186K Buy
38,947
+4,024
+12% +$18.7K ﹤0.01% 2621
2023
Q4 		$168K Buy
34,923
+575
+2% +$3.52K ﹤0.01% 2688
2023
Q3 		$249K Hold
34,348
– – ﹤0.01% 2466
2023
Q2 		$255K Buy
+34,348
New +$270K ﹤0.01% 2465
2021
Q4 		– Sell
-1,298
Closed -$269K – 3160
2021
Q3 		$269K Hold
1,298
– – ﹤0.01% 2759
2021
Q2 		$276K Sell
1,298
-33,089
-96% -$6.06M ﹤0.01% 2872
2021
Q1 		$6.24M Sell
34,387
-2,213
-6% -$441K 0.01% 1168
2020
Q4 		$4.08M Buy
36,600
+1,416
+4% +$151K ﹤0.01% 1302
2020
Q3 		$3.81M Buy
35,184
+1,174
+3% +$143K ﹤0.01% 1215
2020
Q2 		$2.84M Buy
34,010
+14,206
+72% +$543K ﹤0.01% 1305
2020
Q1 		$269K Buy
19,804
+4,254
+27% +$36K ﹤0.01% 2163
2019
Q4 		$62K Sell
15,550
-681
-4% -$2.95K ﹤0.01% 2841
2019
Q3 		$91K Hold
16,231
– – ﹤0.01% 2843
2019
Q2 		$95K Buy
16,231
+3,030
+23% +$23.8K ﹤0.01% 2888
2019
Q1 		$145K Buy
13,201
+138
+1% +$4.36K ﹤0.01% 2515
2018
Q4 		$481K Buy
13,063
+386
+3% +$15K ﹤0.01% 1984
2018
Q3 		$477K Sell
12,677
-1,853
-13% -$52.2K ﹤0.01% 2333
2018
Q2 		$389K Buy
14,530
+2,689
+23% +$90.9K ﹤0.01% 2586
2018
Q1 		$497K Sell
11,841
-534
-4% -$21.5K ﹤0.01% 2328
2017
Q4 		$307K Buy
12,375
+1,065
+9% +$26K ﹤0.01% 2681
2017
Q3 		$258K Sell
11,310
-310
-3% -$6.94K ﹤0.01% 2775
2017
Q2 		$267K Buy
11,620
+705
+6% +$13.8K ﹤0.01% 2775
2017
Q1 		$280K Buy
10,915
+1,346
+14% +$37K ﹤0.01% 2598
2016
Q4 		$242K Buy
9,569
+368
+4% +$10.7K ﹤0.01% 2633
2016
Q3 		$383K Buy
9,201
+3
+0% +$387 ﹤0.01% 2254
2016
Q2 		$1.34M Buy
9,198
+295
+3% +$33.8K ﹤0.01% 1471
2016
Q1 		$915K Buy
8,903
+134
+2% +$14.4K ﹤0.01% 1658
2015
Q4 		$1.47M Buy
8,769
+13
+0.1% +$2K ﹤0.01% 1471
2015
Q3 		$1.24M Buy
8,756
+231
+3% +$51.8K ﹤0.01% 1506
2015
Q2 		$1.9M Buy
8,525
+629
+8% +$111K ﹤0.01% 1431
2015
Q1 		$1.31M Buy
7,896
+284
+4% +$46.1K ﹤0.01% 1534
2014
Q4 		$903K Sell
7,612
-157
-2% -$16.4K ﹤0.01% 1653
2014
Q3 		$648K Buy
7,769
+1,099
+16% +$99.3K ﹤0.01% 1823
2014
Q2 		$616K Sell
6,670
-375
-5% -$33K ﹤0.01% 1896
2014
Q1 		$638K Buy
7,045
+252
+4% +$28.2K ﹤0.01% 1914
2013
Q4 		$696K Buy
6,793
+1,301
+24% +$91.9K ﹤0.01% 1845
2013
Q3 		$347K Sell
5,492
-162
-3% -$9.12K ﹤0.01% 2231
2013
Q2 		$232K Buy
+5,654
New +$245K ﹤0.01% 2450

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NVAX Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Novavax (NVAX) stake by 2% in Q2 2026, selling an estimated $11.7K and leaving 65,202 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

Manulife (Manufacturers Life Insurance) first reported a position in NVAX in Q2 2013 and has held it in 47 quarters since. The position peaked at $6.24M in Q1 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 65,202 shares of Novavax worth $614K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 1,308 Novavax shares in Q2 2026, an estimated $11.7K.
  • Novavax made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2153 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Novavax in Q2 2013 and has held it in 47 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Novavax position peaked at $6.24M in Q1 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.